Comparative study of adjuvants for allergen-specific immunotherapy in a murine model

被引：12
|
作者：
Vazquez de la Torre, Maria [1 ]
Luisa Baeza, Maria [2 ,3 ,4 ]
Najera, Laura [5 ]
Manuel Zubeldia, Jose [2 ,3 ,4 ]
机构：
[1] Infanta Leonor Univ Hosp, Allergy Serv, Madrid, Spain
[2] Gregorio Maranon Univ Gen Hosp, Allergy Serv, Madrid, Spain
[3] Biomed Res Network Rare Dis CIBERER U761, Madrid, Spain
[4] Gregorio Maranon Hlth Res Inst, Madrid, Spain
[5] Puerta Hierro Majadahonda Univ Hosp, Patol Serv, Madrid, Spain
来源：
IMMUNOTHERAPY | 2018年 / 10卷 / 14期
关键词：
adjuvants; allergen-specific immunotherapy; allergic asthma; aluminum hydroxide; calcium phosphate; immunostimulatory sequences; monophosphoryl lipid A; murine model; INDUCED AIRWAY INFLAMMATION; IGE ANTIBODY-FORMATION; CPG OLIGODEOXYNUCLEOTIDES; IMMUNE-RESPONSE; IMMUNOSTIMULATORY DNA; EXPERIMENTAL ASTHMA; TH1; RESPONSES; MICE; HYPERRESPONSIVENESS; INDUCTION;
D O I：
10.2217/imt-2018-0072
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Aim: To compare the immunological and clinical changes induced by allergen-specific immunotherapy (AIT) using different adjuvants. Materials & methods:Olea europaea pollen-sensitized mice were treated with olea plus aluminum hydroxide, calcium phosphate, monophosphoryl lipid A (MPL) or immunostimulatory sequences (ISS). Results: Aluminum hydroxide seems to drive initially to a Th2-type response. Bacteria-derived adjuvants (MPL and ISS) skew the immune response toward Th1 and Treg pathways. Specific-IgE production was lower after AIT with MPL and ISS. Moreover, IgG2a production significantly increased in ISS-treated mice. Bacteria-derived adjuvants also improved the Th1 cytokine response due to IFN- higher secretion. In addition, they improved bronchial hyper-reactivity and lung inflammation. Conclusion: Bacteria-derived adjuvants may enhance the efficacy of AIT.
引用
收藏
页码：1219 / 1228
页数：10
相关论文
共 50 条
  • [31] The Future of Allergen-Specific Immunotherapy
    Jutel, Marek
    Solarewicz-Madejek, Katarzyna
    Smolinska, Sylwia
    DRUG INFORMATION JOURNAL, 2012, 46 (06): : 683 - 687
  • [32] Allergen-specific immunotherapy in Kazakhstan
    Ispayeva, Z.
    ALLERGY, 2012, 67 : 521 - 521
  • [33] Mechanisms of allergen-specific immunotherapy
    Akdis, Muebeccel
    Akdis, Cezmi A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (04) : 780 - 789
  • [34] Advances in allergen-specific immunotherapy
    Verhagen, J
    Taylor, A
    Akdis, CA
    Akdis, M
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (04) : 537 - 544
  • [35] Intralymphatic allergen-specific immunotherapy
    Kang, Sung-Moon
    Jung, Joo Hyun
    Lee, Sang Min
    Lee, Sang Pyo
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2020, 8 (02): : 53 - 65
  • [36] Mechanisms of allergen-specific immunotherapy
    Akdis, Cezmi A.
    Akdis, Muebeccel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (01) : 18 - 27
  • [37] Allergen-specific immunotherapy in children
    El-Sayed, Zeinab A.
    El-Farghali, Ola G.
    EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGY, 2012, 10 (02): : 55 - 66
  • [38] Future of allergen-specific Immunotherapy
    Novak, N.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 81 - 81
  • [39] Allergen-specific immunotherapy Regulatory T cells or allergen-specific IgG?
    Kuendig, Thomas M.
    Bachmann, Martin F.
    HUMAN VACCINES, 2010, 6 (08): : 673 - 675
  • [40] Allergen-Specific Immunotherapy in Asthma
    Jutel M.
    Current Treatment Options in Allergy, 2014, 1 (2) : 213 - 219
12345